Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
A 66-year-old patient with metastatic renal clear cell carcinoma, developed palpable purpura during systemic treatment with different tyrosine kinase inhibitors (TKI).
Main Authors: | Diogo Alpuim Costa, Susana Baptista de Almeida, Pedro Coelho Barata, António Quintela, Pedro Cabral, Ana Afonso, João Maia Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
José de Mello Saúde
2018-05-01
|
Series: | Gazeta Médica |
Subjects: | |
Online Access: | http://www.gazetamedica.pt/index.php/gazeta/article/view/147 |
Similar Items
-
Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach
by: Diogo Alpuim Costa, et al.
Published: (2017-11-01) -
An uncommon coexistence of sarcoidosis and cutaneous leukocytoclastic vasculitis in an adult
by: Birsen Ocakli, et al.
Published: (2019-01-01) -
Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
by: Dana Blyth, et al.
Published: (2012-01-01) -
Rare Association of Leukocytoclastic Vasculitis in Visceral Leishmaniaisis
by: Bharath A. Chhabria1*,, et al.
Published: (2019-01-01) -
Impending central retinal vein occlusion in patient with idiopathic cutaneous leukocytoclastic vasculitis
by: Amir Akhavanrezayat, et al.
Published: (2020-12-01)